Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
2013 · Critical Care · 1,332 citations
https://doi.org/10.1186/cc12503
T
Thomas Rimmelé
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
597
Papers
17.0K
Citations
63
h-index
251
i10-index
Thomas Rimmelé is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Solar and Space Plasma Dynamics & Adaptive optics and wavefront sensing & Sepsis Diagnosis and Treatment. The author has an h-index of 63, co-authored 508 publications.
ORCID: 0000-0002-7213-9787Papers by this author
worksCOVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
2020 · Nature Reviews Nephrology · 699 citations
https://doi.org/10.1038/s41581-020-00356-5
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
2023 · Nature Reviews Nephrology · 598 citations
https://doi.org/10.1038/s41581-023-00683-3
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
2020 · Kidney International · 523 citations
https://doi.org/10.1016/j.kint.2020.04.020
36th International Symposium on Intensive Care and Emergency Medicine
2016 · Critical Care · 496 citations
https://doi.org/10.1186/s13054-016-1208-6
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
2018 · JCI Insight · 391 citations
https://doi.org/10.1172/jci.insight.98960
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat